EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Innovations in Platelet Cryopreservation: Evaluation of DMSO-Free Controlled-Rate Freezing and the Role of a Deep Eutectic Solvent as an Additional Cryoprotective Agent

Rahel Befekadu, Natasha Bosnjak, Michael Uhlin iD, Agneta Wikman, Per Sandgren

International Journal of Molecular Sciences · 15.10.2025 · 26 (20) · 10013

DOI: 10.3390/ijms262010013 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 15.10.2025. Verfasst von Rahel Befekadu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Immunology and Transfusion Medicine (KITM), Karolinska University Hospital, SE-14186 Huddinge, Sweden. Hauptthemen laut MEDLINE: Cryopreservation, Cryoprotective Agents, Blood Platelets, Blood Preservation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European blood alliance (EBA) through its Executive Officers, Brussels, Belgium., European blood alliance.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cryopreservation is a well-established method for extending platelet shelf-life and addressing supply shortages. Traditionally, this involves dimethyl sulfoxide (DMSO) as a cryoprotective agent (CPA), but recent studies suggest that using controlled rate freezing (CRF) with only NaCl may offer a less toxic alternative. To explore further optimization, this study assessed whether adding 10% choline chloride–glycerol, a deep eutectic solvent (DES), could enhance platelet quality in CRF/NaCl cryopreservation. Ten double-dose buffy coat platelet units were divided into test (DES-treated) and control (NaCl-only) groups. After DES exposure (10% for 20 min), all units were prepared using the NaCl protocol and frozen at −80 °C with CRF equipment, then stored for over 90 days. Upon thawing and reconstitution in AB plasma, no significant differences were observed in platelet content post-thaw between control and test units (255 ± 43 vs. 257 ± 41 × 109/unit), post-thaw recovery (>85%): respectively, Δψ (JC-1% pos 63 ± 15 vs. 68 ± 17), LDH (% of total 10 ± 6 vs. 9 ± 6), (CD63% 77 ± 9 vs. 82 ± 7), (CD62P % 72 ± 15 vs. 76 ± 11), (CD42b % 78 ± 9 vs. 80 ± 9), (CD61% 79 ± 9 vs. 78 ± 9), (CD41% 81 ± 11 vs. 83 ± 7), (PAC-1% 33 ± 10 vs. 32 ± 8), (Pecam-1% 78 ± 11 vs. 80 ± 8), (GPIV % 72 ± 10 vs. 74 ± 11), (LAMP-1% 26 ± 14 vs. 11 ± 9), (MPCD61+ % 41 ± 11 vs. 46 ± 10), (ROTEM CT 56 ± 7 vs. 55 ± 6), (ROTEM CFT 110 ± 70 vs. 106 ± 67) and (ROTEM MCF 35 ± 6 vs. 36 ± 6). These findings support the feasibility of CPA-free CRF-based platelet cryopreservation while maintaining functional integrity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CryopreservationCryoprotective AgentsBlood PlateletsBlood PreservationDeep Eutectic SolventsHumansDimethyl SulfoxideFreezingGlycerolCholine

Stichwörter der Autor:innen

DMSO-free cryopreservationcontrolled-rate freezing (CRF)deep eutectic solvents (DES)dimethyl sulfoxide (DMSO, Me2SO)platelets

Substanzen

Cryoprotective AgentsDimethyl SulfoxideDeep Eutectic SolventsGlycerolCholine

Autor:innen und Institutionen

  • Clinical Immunology and Transfusion Medicine (KITM), Karolinska University Hospital, SE-14186 Huddinge, Sweden.
  • Hematology and Regenerative Medicine (HERM), Karolinska Institutet, SE-14186 Huddinge, Sweden.

ORCID-Profile: Michael Uhlin

Förderung

  • European blood alliance (EBA) through its Executive Officers, Brussels, Belgium.
  • European blood alliance

Zitieren

APA

Befekadu, R., Bosnjak, N., Uhlin, M., Wikman, A., & Sandgren, P. (2025). Innovations in Platelet Cryopreservation: Evaluation of DMSO-Free Controlled-Rate Freezing and the Role of a Deep Eutectic Solvent as an Additional Cryoprotective Agent. International Journal of Molecular Sciences, 26(20), 10013. https://doi.org/10.3390/ijms262010013

Vancouver

Befekadu R, Bosnjak N, Uhlin M, Wikman A, Sandgren P. Innovations in Platelet Cryopreservation: Evaluation of DMSO-Free Controlled-Rate Freezing and the Role of a Deep Eutectic Solvent as an Additional Cryoprotective Agent. International Journal of Molecular Sciences. 2025;26(20):10013. doi:10.3390/ijms262010013

BibTeX
@article{Befekadu2025,
  author = {Befekadu, Rahel and Bosnjak, Natasha and Uhlin, Michael and Wikman, Agneta and Sandgren, Per},
  title = {Innovations in Platelet Cryopreservation: Evaluation of DMSO-Free Controlled-Rate Freezing and the Role of a Deep Eutectic Solvent as an Additional Cryoprotective Agent},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {20},
  pages = {10013},
  doi = {10.3390/ijms262010013}
}
Kostenlos starten →